5913 Results

People

  1. Ladanyi
    Ladanyi
  2. Solit
    Solit
  3. Levine
    Levine
  4. Berger
    Berger
  5. Schultz
    Schultz
  6. Arcila
    Arcila
  7. Hakimi
    Hakimi
  8. Chandarlapaty
    Chandarlapaty
  9. Zehir
    Zehir
  10. Mellinghoff
    Mellinghoff

Groups

  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)
  7. Sloan Kettering Institute Postdocs (1984)
  8. Hematologic Malignancies, Division of (1879)
  9. Center for Hematologic Malignancies (1845)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (1735)
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2984)
  2. Meeting Abstract (2526)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (41)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (15)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)

More Groups

People
  1. Marc Ladanyi (1326)
  2. David Solit (779)
  3. Ross Levine (774)
  4. Michael Berger (765)
  5. Nikolaus Schultz (486)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (119)
  2. 2024 (359)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (636)
  2. Blood (495)
  3. Cancer Research (412)
  4. Modern Pathology (299)
  5. Clinical Cancer Research (268)
  6. Laboratory Investigation (262)

More Publications

Publishers
  1. American Association for Cancer Research (871)
  2. Nature Publishing Group (757)
  3. American Society of Clinical Oncology (702)
  4. American Society of Hematology (541)
  5. Elsevier Inc. (420)
  6. Nature Research (312)

More Publishers

Results (5913)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The alveolar soft part sarcoma marker TFE3 is also frequently expressed in granular cell tumor
    Meeting Abstract

    Zhu, C.; Melamed, J.; Sidhu, G.; Argani, P.; Ladanyi, M.; Illei, P.
    Modern Pathology (2005)

    Fulltext@MSK | Save
  • The alveolar soft part sarcoma marker TFE3 is also frequently expressed in granular cell tumor
    Meeting Abstract

    Zhu, C.; Melamed, J.; Sidhu, G.; Argani, P.; Ladanyi, M.; Illei, P.
    Laboratory Investigation (2005)

    Fulltext@MSK | Save
  • EGFR and KRAS mutational analysis of mucinous pneumonic bronchiololavelolar carcinomas
    Meeting Abstract

    Zakowski, M.; Ladanyi, M.; Kris, M.; Rusch, V.; Pao, W.
    Lung Cancer (2005)

    Fulltext@MSK | Save
  • Killer immunoglobulin-like receptor ligand (KIR-L) mismatched natural killer (NK) cells for relapsed myeloma
    Meeting Abstract

    Van Rhee, F.; Shi, J.; Szmania, S.; Rosen, N.; Moreno, A.; Walker, R.; Dupont, B.; Hsu, K.; Baxter-Lowe, L. A.; Campana, D.; more...
    Journal of Immunotherapy (2005)

    Fulltext@MSK | Save
  • FLT PET as a non-invasive marker of response to MEK inhibition
    Meeting Abstract

    Solit, D. B.; Santos, E.; Pratilas, C.; Moroz, M.; Blasberg, R.; Sebolt-Leopold, J.; Larson, S. M.; Rosen, N.
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save
  • Phase 1 pharmacokinetic and pharmacodynamic trial of docetaxel and 17AAG (17-allylamino-17-demethoxygeldanamycin)
    Meeting Abstract

    Solit, D. B.; Egorin, M.; Kopil, C.; Delacruz, A.; Shaffer, D.; Slovin, S.; Morris, M.; Kelly, W. K.; Rosen, N.; Scher, H.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Inhibitors of Hsp90 induce the degradation of HER2 and inhibit the growth of HER2-dependent breast tumors
    Meeting Abstract

    Solit, D. B.; Basso, A.; Smith-Jones, P.; Modi, S.; Norton, L.; Larson, S.; Neckers, L.; Scher, H.; Hudis, C.; Rosen, N.
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Killer immunoglobulin-like receptor ligand (KIR-lig) mismatched natural killer (NK) cell transfusions for multiple myeloma (MM)
    Meeting Abstract

    Shi, J.; Szmania, S.; Rosen, N.; Moreno, A.; Walker, R.; Dupont, B.; Hsu, K.; Baxter-Lowe, L. A.; Shaughnessy, J.; Barlogie, B.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • Genetic and pharmacological inhibition of p13 kinase signaling in vivo sensitizes tumors to EGFR inhibitors and to taxol
    Meeting Abstract

    She, Q. B.; Ye, Q.; She, Y. H.; Solit, D.; Gibbons, J.; Rosen, N.
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save
  • A phase I/II trial to assess tolerability and efficacy of RAD-001 with gefitinib in patients with glioblastoma multiforme and castrate metastatic prostate cancer
    Meeting Abstract

    Shaffer, D. R.; Abrey, L.; Beekman, K.; Morris, M.; Eicher, C.; Kelly, W. K.; Slovin, S.; Solit, D.; Rosen, N.; Scher, H. I.
    EJC Supplements (2005)

    Fulltext@MSK | Save